PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:32 AM ET

Sponsor Check › Person

TK
No photo found yet (own website and image search run after this page is viewed)

Timothy Ko

Named as an officer, director or promoter on SEC Form D filings · British Columbia, Canada (as filed: A1) · Jun 22, 2020 → Feb 3, 2021

2deals (issuers)
$109Kreported sold
5investors
2Form D filings
2020–2021years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:46 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Timothy Ko is listed as an executive officer and director on 2 SEC Form D filings by 2 issuers between Jun 2020 and Feb 2021: Entheon Biomedical Corp. (Belcarra, British Columbia, Canada (as filed: A1) — other health care — 2020; $77K reported sold to 4 investors) and Entheon Biomedical Corp. / Federal (Coquitlam, British Columbia, Canada (as filed: A1) — biotechnology — 2021; $31K reported sold to 1 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director. Across those companies the filings report $109K sold in total.

Listed alongside Andrew Hegle (2 shared filings), Brandon Schwabe (2 shared filings), Christopher Gondi (2 shared filings), Kelly Pladson (2 shared filings) and Ruth Chun (1 shared filing).

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Timothy. Each name links to their own page.

All 2 issuers belong to the sponsor group Entheon Biomedical (2 issuers, $109K reported sold, 2020–2021).

What this means A sponsor group is one team that sets up a new company for each deal. Entheon Biomedical has 2 companies on file and $109K reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 2 public filings for Timothy Ko and found 5 differences: Timothy Ko appears on 2 deals that stopped filing before reaching their target; Form D filed 23 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Timothy Ko has not run yet — it is joining a line of 23,566 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:46 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Timothy Ko..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:46 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

5 differences found between the filings for Timothy Ko (compared 2 filings on Oct 24, 2026)

Note · Jun 22, 2020 – Feb 3, 2021

Timothy Ko appears on 2 deals that stopped filing before reaching their target

Entheon Biomedical Corp. / Federal (last filing Feb 3, 2021; $31,390 sold of $1,707,188); Entheon Biomedical Corp. (last filing Jun 22, 2020; $77,279 sold of $1,297,096). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Sources
Note · Jan 11, 2021 – Feb 3, 2021

Form D filed 23 days after the first sale — Entheon Biomedical Corp. / Federal

The filing says the first sale was Jan 11, 2021. The Form D was filed Feb 3, 2021 — 23 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 8 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 3, 2020 – Jun 22, 2020

Form D filed 19 days after the first sale — Entheon Biomedical Corp.

The filing says the first sale was Jun 3, 2020. The Form D was filed Jun 22, 2020 — 19 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 4 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jan 11, 2021 – Feb 3, 2021

No amendment in the last 12 months on an offering that may still be open — Entheon Biomedical Corp. / Federal (latest filing Feb 3, 2021)

The latest filing for this offering is dated Feb 3, 2021 (first sale Jan 11, 2021). It reports $31,390 sold of $1,707,188 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 3, 2020 – Jun 22, 2020

No amendment in the last 12 months on an offering that may still be open — Entheon Biomedical Corp. (latest filing Jun 22, 2020)

The latest filing for this offering is dated Jun 22, 2020 (first sale Jun 3, 2020). It reports $77,279 sold of $1,297,096 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 2 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 3, 2021 D
Entheon Biomedical Corp. / Federal
File 021-388338
$0$0$0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
None listed on this filingEDGAR ↗
Jun 22, 2020 D
Entheon Biomedical Corp.
File 021-369415
$0$0$0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Timothy Ko on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology · group: Entheon Biomedical

Entheon Biomedical Corp. / Federal

Coquitlam, British Columbia, Canada (as filed: A1) · Feb 3, 2021
  • Feb 3, 2021 · D · $31,390 sold of $1,707,188 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $31K from 1 investor (2% of the $1.71M target) as of the latest filing. Timothy is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Entheon Biomedical

Entheon Biomedical Corp.

Belcarra, British Columbia, Canada (as filed: A1) · Jun 22, 2020
  • Jun 22, 2020 · D · $77,279 sold of $1,297,096 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $77K from 4 investors (6% of the $1.3M target) as of the latest filing. Timothy is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Timothy 5

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

KP
No photo found yet (own website and image search run after this page is viewed)
Person

Kelly Pladson

Executive Officer · 2 shared filings (2 issuers) · also on 13 other issuers

Kelly Pladson is on 15 issuers in total — a repeat sponsor. Their page lists every one.

AH
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Hegle

Director, Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Timothy Ko. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Gondi

Director · 2 shared filings (2 issuers)

Listed on the same filings as Timothy Ko. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brandon Schwabe

Executive Officer, Director · 2 shared filings (2 issuers)

Listed on the same filings as Timothy Ko. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Ruth Chun

Director · 1 shared filing (1 issuer)

Listed on the same filings as Timothy Ko. Their page shows their other deals.

The team behind the deals

Sponsor group

Entheon Biomedical

2 issuers · 2 filings · $109K reported sold · 2020–2021

One team, 2 deal companies. Timothy Ko is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Timothy Ko.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Timothy Ko by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Timothy Ko is listed on: none on file. No website or social profile named in Entheon Biomedical Corp.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #213,543 of 374,652 in line (1,189 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Belcarra, A1). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Business registries

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Timothy Ko appears on a new Form D, or when a court case or SEC action is matched to them. See plans →